Results 181 to 190 of about 2,833,000 (351)

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Prevalance of inducible clindamycin resistance of Staphylococcus aureus from various clinical specimens by D test in tertiary care hospital

, 2014
Dr Vyoma chudasama, Hasumati L. Solanki, Minesh G Vadsmiya, Dr M M Vegad   +3 more
openalex   +1 more source

Quetiapine‐induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference [PDF]

, 2012
Yutaro Suzuki, Takuro Sugai, Naoki Fukui, Junzo Watanabe, Shin Ono, Nobuto Tsuneyama, Mami Saito, Toshiyuki Someya   +7 more
openalex   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Investigation of inducible clindamycin resistance in methicillin resistant Staphylococcus aureus strains

, 2017
Hayrünisa Hancı, Ahmet Ayyıldız, Hakan İgan   +2 more
openalex   +2 more sources

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Editorial: Induced resistance and priming against pests and pathogens

Frontiers in Plant Science, 2022
Michele Perazzolli, Michele Perazzolli, Jurriaan Ton, Estrella Luna, Brigitte Mauch-Mani, Maria L. Pappas, Michael R. Roberts, A. Corina Vlot, Víctor Flors   +8 more
doaj   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Figure S4 from Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents

, 2023
Andrea L. Casillas, Rachel K. Toth, Alva G. Sainz, Neha Singh, Ankit A. Desai, Andrew S. Kraft, Noel A. Warfel   +6 more
openalex   +1 more source

Specific phenotypic, genomic, and fitness evolutionary trajectories toward streptomycin resistance induced by pesticide co-stressors in Escherichia coli [PDF]

, 2021
Yue Xing, Xiaoxi Kang, Siwei Zhang, Yujie Men   +3 more
openalex   +1 more source